Breaking News Instant updates and real-time market news.

FSP

Franklin Street

$8.25

(0.00%)

09:23
04/09/18
04/09
09:23
04/09/18
09:23

Franklin Street lowers dividend to 9c per share

Franklin Street Properties announced after the close on Friday that its board of directors declared a regular quarterly dividend of 9c per share of common stock for the period January 1, 2018 through March 31, 2018, payable on May 10 to stockholders of record as of April 20. Chairman and CEO George Carter said, "The declared quarterly dividend of $0.09 per share of common stock represents a $0.10 reduction from the $0.19 per share of common stock quarterly dividend that FSP has paid since August 2008. As indicated in our fourth quarter 2017 earnings press release, the transition of FSP's property portfolio from a suburban to a primarily urban orientation has generally resulted in higher leasing costs per square foot but longer lease terms and higher rental rates. We anticipate that we will have the opportunity to do significant leasing in the property portfolio during 2018 and 2019 with the objective of achieving 92% to 94% stabilized occupancy. While some of the leasing to be done is rollover space from existing tenant lease expirations, a large amount is associated with value-add opportunities that exist in currently vacant space in many of our recently acquired urban-infill properties. The currently declared dividend of $0.09 per share of common stock has been set at a level that our Board of Directors believes will better enable us to fund anticipated capital expenditures and leasing costs from internal cash flow and that will more closely align our percentage of AFFO, or adjusted funds from operations, payout with other office REITs."

FSP Franklin Street
$8.25

(0.00%)

02/15/18
02/15/18
DOWNGRADE
Target $7

Sell
Franklin Street downgraded to Sell on dividend concerns at Stifel
As previously reported, Stifel analyst John Guinee downgraded Franklin Street Properties to Sell from Hold as he thinks its dividend may be cut, believes its lease economics continue to indicate value erosion at the lease level and sees the significant value erosion in 2017 to become worse in 2018. The analyst, who said a dividend cut may possibly be required by lenders, thinks a 50c per share dividend would be appropriate to be in line with Franklin's peer group. Guinee lowered his price target on Franklin Street to $7 from $10.
02/27/18
BMOC
02/27/18
DOWNGRADE
BMOC
Underperform
Franklin Street downgraded to Underperform from Market Perform at BMO Capital
02/27/18
BMOC
02/27/18
DOWNGRADE
Target $8
BMOC
Underperform
Franklin Street cut to Underperform at BMO Capital after soft FY18 outlook
As reported earlier, BMO Capital analyst John Kim downgraded Franklin Street to Underperform from Market Perform and lowered his price target to $8 from $10.50. Kim says the company's soft FY18 outlook that showed a 6% decline in expected FFO suggests that the REIT's dividend could be cut by at least 40% to get its payout ratio in line with peers. The analyst believes that there is no clear path to near-term earnings recovery.
04/09/18
JANY
04/09/18
DOWNGRADE
JANY
Neutral
Franklin Street downgraded to Neutral from Buy at Janney Capital

TODAY'S FREE FLY STORIES

CBM

Cambrex

$47.67

0.41 (0.87%)

06:42
11/20/18
11/20
06:42
11/20/18
06:42
Hot Stocks
Cambrex to acquire Avista Pharma Solutions for approximately $252M »

Cambrex announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QLYS

Qualys

$69.24

-5.355 (-7.18%)

06:41
11/20/18
11/20
06:41
11/20/18
06:41
Upgrade
Qualys rating change  »

Qualys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Jan

JD

JD.com

$21.09

-1.95 (-8.46%)

06:38
11/20/18
11/20
06:38
11/20/18
06:38
Downgrade
JD.com rating change  »

JD.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$21.09

-1.95 (-8.46%)

06:35
11/20/18
11/20
06:35
11/20/18
06:35
Periodicals
JD.com CEO says focus will be on strategy, new businesses, Yicai reports »

JD.com founder and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRL

Hormel Foods

$45.36

-0.535 (-1.17%)

06:35
11/20/18
11/20
06:35
11/20/18
06:35
Earnings
Breaking Earnings news story on Hormel Foods »

Hormel Foods sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TGT

Target

$77.13

-1.9 (-2.40%)

06:34
11/20/18
11/20
06:34
11/20/18
06:34
Earnings
Breaking Earnings news story on Target »

Target sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

TGT

Target

$77.13

-1.9 (-2.40%)

06:34
11/20/18
11/20
06:34
11/20/18
06:34
Hot Stocks
Breaking Hot Stocks news story on Target »

Target sees Q4 SSS up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

MMS

Maximus

$63.91

-2.05 (-3.11%)

06:33
11/20/18
11/20
06:33
11/20/18
06:33
Earnings
Maximus sees FY19 revenue $2.95B-$3.0B, consensus $2.53B »

Sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TGT

Target

$77.13

-1.9 (-2.40%)

06:33
11/20/18
11/20
06:33
11/20/18
06:33
Earnings
Target reports Q3 adj. EPS $1.09, consensus $1.12 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

HRL

Hormel Foods

$45.36

-0.535 (-1.17%)

06:32
11/20/18
11/20
06:32
11/20/18
06:32
Earnings
Hormel Foods reports Q4 adj. EPS 51c, consensus 49c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MMS

Maximus

$63.91

-2.05 (-3.11%)

06:31
11/20/18
11/20
06:31
11/20/18
06:31
Earnings
Maximus reports Q4 revenue $558.4M, consensus $587.58M »

Reports Q4 EPS 71c vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HSDT

Helius Medical

$8.02

-0.08 (-0.99%)

06:31
11/20/18
11/20
06:31
11/20/18
06:31
Upgrade
Helius Medical rating change  »

Helius Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWD

Woodward

$79.45

-2.46 (-3.00%)

06:30
11/20/18
11/20
06:30
11/20/18
06:30
Upgrade
Woodward rating change  »

Woodward upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

QEP

QEP Resources

06:27
11/20/18
11/20
06:27
11/20/18
06:27
Upgrade
QEP Resources rating change  »

QEP Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$45.12

-1.48 (-3.18%)

06:27
11/20/18
11/20
06:27
11/20/18
06:27
Downgrade
Western Digital rating change  »

Western Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EQIX

Equinix

, KNX

Knight-Swift

$32.23

0.51 (1.61%)

06:26
11/20/18
11/20
06:26
11/20/18
06:26
Recommendations
Equinix, Knight-Swift analyst commentary  »

Equinix, Knight-Swift…

EQIX

Equinix

KNX

Knight-Swift

$32.23

0.51 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 10

    Dec

DHI

D.R. Horton

$34.98

0.19 (0.55%)

, KSU

Kansas City Southern

$98.99

-1.795 (-1.78%)

06:26
11/20/18
11/20
06:26
11/20/18
06:26
Recommendations
D.R. Horton, Kansas City Southern analyst commentary  »

D.R. Horton, Kansas City…

DHI

D.R. Horton

$34.98

0.19 (0.55%)

KSU

Kansas City Southern

$98.99

-1.795 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 05

    Dec

SWKS

Skyworks

06:25
11/20/18
11/20
06:25
11/20/18
06:25
Downgrade
Skyworks rating change  »

Skyworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$35.26

-1.15 (-3.16%)

06:25
11/20/18
11/20
06:25
11/20/18
06:25
Downgrade
Teradyne rating change  »

Teradyne downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$21.08

-0.75 (-3.44%)

, ACHC

Acadia

$32.05

-0.51 (-1.57%)

06:23
11/20/18
11/20
06:23
11/20/18
06:23
Periodicals
KKR still in talks to buy Acadia Healthcare, NY Post reports »

KKR (KKR) is still deep…

KKR

KKR

$21.08

-0.75 (-3.44%)

ACHC

Acadia

$32.05

-0.51 (-1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$78.54

-0.79 (-1.00%)

, AET

Aetna

$207.68

-1.49 (-0.71%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Hot Stocks
CVS Health, Aetna deal expected to close after Thanksgiving holiday »

In connection with the…

CVS

CVS Health

$78.54

-0.79 (-1.00%)

AET

Aetna

$207.68

-1.49 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$32.46

-1.22 (-3.62%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Downgrade
Ciena rating change  »

Ciena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Helius Medical rating change  »

Helius Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QLYS

Qualys

$69.24

-5.355 (-7.18%)

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Qualys rating change  »

Qualys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Jan

NERV

Minerva

$8.32

-0.09 (-1.07%)

06:17
11/20/18
11/20
06:17
11/20/18
06:17
Conference/Events
Minerva management to host key opinion leader breakfast meeting »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.